Peri-implantitis - Reconstructive Surgical Therapy
NCT: NCT03077061 · ACTIVE_NOT_RECRUITING
Brief Summary
The project will evaluate the potential benefit of the use of bone replacement graft as an adjunct to surgical therapy of peri-implantitis. The project will be conducted as a two-armed randomized controlled clinical trial of 5-year duration in 7 clinical centers. 140 systemically healthy patients diagnosed with peri-implantitis will randomly assigned to be treated with or without bone replacement graft. Outcome measures include assessments of inflammation, probing depth, recession, radiological parameters and PROMs.
Frequently Asked Questions
What is Peri-implantitis - Reconstructive Surgical Therapy?
Peri-implantitis - Reconstructive Surgical Therapy is a clinical trial registered under NCT03077061. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT03077061?
The current status of NCT03077061 (Peri-implantitis - Reconstructive Surgical Therapy) is: ACTIVE_NOT_RECRUITING.
When did Peri-implantitis - Reconstructive Surgical Therapy start?
Peri-implantitis - Reconstructive Surgical Therapy started on 2017-04-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.